Recall D-1337-2022
Description: Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Recall D-1337-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1337-2022 |
| Event ID | 90551 |
| Distribution | The product was distributed nationwide in the USA and Canada. |
| Quantity | 1000 10-count tins |
| Recall Reason | Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug. |
| Drug Classification | Class I |
| Drug Code Info | 20220727 |
| Recall Initiation Date | 20220627 |
| Report Date | 20220727 |
| Classification Date | 20220815 |
| Address | 300 Oser Ave Hauppauge, NY 11788-3608 United States |
| Recalling Firm | Loud Muscle Science |
| Initial Notification | Press Release |
| Similar To |